We have located links that may give you full text access.
Effects of dietary sodium and protein intake on glomerular filtration rate in subjects with type 2 diabetes treated with sodium glucose cotransporter 2 inhibitors.
Experimental and Clinical Endocrinology & Diabetes 2023 Februrary 24
BACKGROUND: Approximately one forth of patients treated with SGLT2 inhibitors (SGLT2i) experience an acute estimated glomerular filtration rate (eGFR) reduction of more than 10% ("dippers"). High sodium and protein intake can increase intraglomerular pressure and predispose to a decline of renal function. We investigated whether measured creatinine clearance (CrCl) is a sensitive enough method to detect the initial dip of GFR and if dietary sodium and protein intake might influence the extent of the early change in GFR.
METHODS: 28 subjects with type 2 diabetes (T2D) were enrolled. 24h urinary samples for sodium and urea determination were collected, to estimate sodium and protein intake respectively before and 1, 3 and 6 months after SGLT2i initiation.
RESULTS: Mean CrCl was 83.23±25.52 ml/min/1.73 m2 (eGFR 67.32±16.07) and dropped by 19% at month 1 (eGFR by 6%). Dippers were 64% and 40%, according to CrCl and eGFR respectively. Exploring the potential correlation between changes in renal function and salt intake, ΔCrCl and baseline urinary sodium were inversely related at month 1 (r= -0,61; p<0.01), at month 3 (r= -0.51; p =0.01) and month 6 (r= -0,48; p<0.05). Likewise, an inverse correlation between ΔCrCl and baseline urinary urea was demonstrated at month 1 and 3 (r= -0.46; p<0.05 for both), at month 6 a similar trend was observed (r= -0.47; p=0.054).
CONCLUSIONS: The present study suggests that a higher dietary sodium and protein intake may amplify the extent of early dip in GFR, as detected with measured CrCl, in diabetic patients undergoing SGLT2i treatment.
METHODS: 28 subjects with type 2 diabetes (T2D) were enrolled. 24h urinary samples for sodium and urea determination were collected, to estimate sodium and protein intake respectively before and 1, 3 and 6 months after SGLT2i initiation.
RESULTS: Mean CrCl was 83.23±25.52 ml/min/1.73 m2 (eGFR 67.32±16.07) and dropped by 19% at month 1 (eGFR by 6%). Dippers were 64% and 40%, according to CrCl and eGFR respectively. Exploring the potential correlation between changes in renal function and salt intake, ΔCrCl and baseline urinary sodium were inversely related at month 1 (r= -0,61; p<0.01), at month 3 (r= -0.51; p =0.01) and month 6 (r= -0,48; p<0.05). Likewise, an inverse correlation between ΔCrCl and baseline urinary urea was demonstrated at month 1 and 3 (r= -0.46; p<0.05 for both), at month 6 a similar trend was observed (r= -0.47; p=0.054).
CONCLUSIONS: The present study suggests that a higher dietary sodium and protein intake may amplify the extent of early dip in GFR, as detected with measured CrCl, in diabetic patients undergoing SGLT2i treatment.
Full text links
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app